Researchers at Foothills Hospital in Calgary, Canada have done research that claims that TIAs (mini strokes) could cause long-term disability, and that clot busting drugs like Actilyse could be used to treat them.
In partnership with Alzheimer's Society and the British Heart Foundation, we are delighted to announce our funding of three new awards in vascular dementia research. This constitutes a combined investment of £2.2 million into a key area of unmet need.
What maintains stroke survivors’ continued use of self-managed computer therapy for aphasia?
Postgraduate fellowship: What is the impact of damaged thinking ability caused by a spontaneous bleed in the brain?
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.
Video interview highlights from ten key trials that presented at ESOC 2016.
The Stroke Association is holding this workshop to set the priorities for vascular dementia research in the UK.
Using transcranial magnetic stimulation (TMS) to enable activation of the damaged part of the brain to be more active in the recovery period after a stroke
Using genetics to understand why disease of the small blood vessels in the brain occurs.
CADASIL is one of the most common genetic causes of stroke and dementia. Currently, there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.